The World Health Organization on Wednesday said it is recommending “widespread use” of a malaria vaccine for children in sub-Saharan Africa and other at-risk regions.
The recommendation for the AS01 formulation of the RTS,S vaccine, also known as Mosquirix™, is largely based on results from an ongoing pilot program in Ghana, Kenya, and Malawi that followed more than 800,000 inoculated children since 2019, the WHO announced.
